Being primarily centred on the patient, my work combines the short-term management of the disease and the long-term of clinical research.
Within the immunology laboratory of the Conception Hospital, we take care of patients suffering from immune system dysfunction: immune deficiencies, inflammatory and autoimmune diseases. In practice, we conduct specialized biology tests to quantify and qualify the immune response complexity and we contribute to the therapeutic decision-making of medical teams.
Inherently complex, these diseases are often a real challenge in terms of diagnosis, prognosis, treatment and monitoring. Our mission therefore is to accelerate the transfer of the latest science and research breakthrough to the clinic to fuel new opportunities for innovation. At the pace of discovery, the laboratory establishes normative values of new classes of immune cells and develops tests that, in turn, will increase the diagnostic power of our analysis. It also conducts interdisciplinary research programs to enhance our knowledge of immunopathology and improve the development of new experimental models.
Being primarily centred on the patient, my work combines the short-term management of the disease and the long-term of clinical research. This approach requires exchanges and interdisciplinarity, two of the main attributes of Marseille Immunopole.#recherche
Together, we pursue a simple goal: to better understand the alterations of energetic metabolism in pancreatic cancer cells
AMU, IPC, CRCM
We and our patients are resolutely committed to the Marseille Immunopôle; patients no longer wish to be simple "providers of biological samples", but full participants in the research process.
Marseille Immunopôle (Marseille Immunology Center) has the potential to provide precious help to open new diagnostic and therapeutic pathways and to provide our patients with even more options.
Cell- and tissue- based therapies and gene therapies hold great promise in the field of both immunotherapy and regenerative medicine.
AMU, IPC, AP-HM, Inserm